Moyamoya Disease and Anesthesia Risks Care
Moyamoya Disease and Anesthesia Risks Care Moyamoya disease is a rare, progressive cerebrovascular disorder characterized by the narrowing or occlusion of the arteries at the base of the brain, particularly the internal carotid arteries and their main branches. This narrowing leads to the development of fragile, abnormal collateral vessels that attempt to compensate for reduced blood flow. The term “moyamoya” is Japanese for “puff of smoke,” describing the hazy appearance of these collateral vessels seen on angiograms. Patients with moyamoya are at increased risk for strokes, transient ischemic attacks, and neurological deficits due to compromised cerebral circulation.
Management of moyamoya disease often involves surgical revascularization procedures to restore adequate blood flow to the brain. However, anesthesia care in these patients presents unique challenges. The primary concern during anesthesia is maintaining stable cerebral perfusion. Because the diseased vessels are fragile and the collateral network is delicate, fluctuations in blood pressure can have significant consequences. Hypotension may lead to ischemia, whereas hypertension can risk rupturing fragile vessels or precipitating hemorrhage. Moyamoya Disease and Anesthesia Risks Care
Anesthesia providers must carefully monitor and control blood pressure throughout the perioperative period. Typically, maintaining normotension or slight hypertension is preferred to ensure sufficient cerebral blood flow without increasing the risk of bleeding. Additionally, anesthetic agents are selected to optimize cerebral hemodynamics. For example, agents that decrease cerebral metabolic rate and intracranial pressure, like propofol, can be advantageous. Conversely, agents that cause significant vasodilation or increase intracranial pressure should be used cautiously.
Moyamoya Disease and Anesthesia Risks Care Another critical aspect is preventing hyperventilation-induced hypocapnia. Excessive lowering of carbon dioxide levels causes cerebral vasoconstriction, which can further reduce blood flow to already compromised areas, risking
ischemic injury. Therefore, ventilation is carefully managed to maintain normal carbon dioxide levels.
Patients with moyamoya disease may also have associated conditions such as hypertension, seizures, or previous strokes, which complicate anesthetic management. Preoperative assessment should include thorough neurological evaluation, imaging studies to delineate vascular anatomy, and optimization of comorbidities. Intraoperatively, meticulous monitoring with invasive blood pressure measurement, electroencephalography (EEG), and cerebral oximetry can help assess cerebral perfusion in real-time. Moyamoya Disease and Anesthesia Risks Care
Moyamoya Disease and Anesthesia Risks Care Postoperative care is equally critical, with vigilant monitoring for neurological changes, hemorrhages, or ischemic events. Adequate pain control, fluid management, and avoiding sudden blood pressure fluctuations are essential components of care to ensure a smooth recovery.
Overall, anesthesia management in moyamoya disease requires a careful, tailored approach that prioritizes stable cerebral perfusion, vigilant monitoring, and prompt response to any hemodynamic changes. Multidisciplinary collaboration involving neurosurgeons, neurologists, and anesthesiologists enhances patient safety and outcomes. Moyamoya Disease and Anesthesia Risks Care